The US market is the engine of the global pharmaceutical industry. Its exceptionally high drug prices help deliver as much as three-quarters of the sector’s global profits. But taxpayer-funded Medicare is set to pull back the throttle. The first round of formal drug price negotiations — enabled by the 2022 Inflation Reduction Act — kicks off this week.
美国市场是manbetx app苹果 制药行业的引擎。其超高的药品价格为行业manbetx app苹果 带来了四分之三的利润。但纳税人资助的联邦医疗保险计划(Medicare)将拉回油门。由2022年《降低通胀法》(Inflation Reduction Act)促成的第一轮正式药品价格谈判将于本周启动。
您已阅读11%（485字），剩余89%（4086字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。